基层医院心房纤颤抗凝治疗现状

Current situation of anticoagulant treatment of atrial fibrillation in primary hospitals

目的了解基层医院心房纤颤抗凝治疗的现状,说明急需在当前临床实践中,重视遵从国际和中国指南,开展以华法林为主的抗凝治疗。方法对县级医院的心房纤颤病人抗凝治疗情况进行调查了解,选取本院在2004年1月至2012年9年间所有住院病人中患有心房纤颤的病患为研究对象,对其相关资料进行综合分析,然后进行分组对比。结果所有调查中的基层医院在心房纤颤方面的凝抗治疗者少之甚少,本院正规化口服华法林抗凝的患者约占0.56%,长期口服阿司匹林的患者约占11.73%,脑卒的发生率约为36%。结论心房颤动(房颤)抗凝治疗是一个非常重要的领域,而基层医院抗凝治疗现状令人堪忧,抗凝治疗不理想的严峻现实和降低房颤卒中率的巨大挑战,需要加强医生及患者对抗凝治疗的充分认识和重视。

Objective To investigate the current situation of anticoagulant treatment of atrial fibrillation （AF） in primary hospitals and to demonstrate the urgent need for warfarin -based anticoagulant treatment according to international and Chinese guidelines in current clinical practice. Methods An investigation was conducted on the anticoagulant treatment among AF patients in county-level hospitals; all AF patients who were hospitalized in our hospital from January 2004 to September 2012 were included in the study; the related data were subjected to comprehensive analysis, and then grouping and comparison were performed. Results Very few patients received anticoagulant treatment of AF in the primary hospitals investigated. In our hospital, about 0.56% of patients received standardized anticoagulant treatment with oral warfarin, and 11.73% of them received oral aspirin for a long time; the incidence of stroke is around 36%. ConclusionAnticoagulant treatment of AF is of great significance, but the current situation of anticoagulant treatment in primary hospitals is concerning. Physicians and patients need to fully understand and attach much importance to anticoagulant treatment to promote anticoagulant treatment and reduce the incidence of stroke in AF patients.